Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Haleon Plc on February 2, 2026, for the month of February 2026. Haleon is a global leader in consumer health with a portfolio spanning Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. The filing specifically addresses the company's total voting rights and capital structure.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. This report is a capital disclosure rather than a financial performance statement.
Material Changes and Capital Structure
As of January 31, 2026, the company reported the following capital data:
- Total Shares Issued: 8,952,353,648 ordinary shares of £0.01 each.
- Treasury Shares: 45,557,120 shares held by the company.
- Voting Shares: 8,906,796,528 ordinary shares with voting rights.
This figure of voting shares serves as the denominator for shareholders to calculate notification obligations under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a statutory notification regarding share capital.
Key Facts for Investor Verification
- Verify the denominator for disclosure calculations is 8,906,796,528 voting shares as of January 31, 2026.
- Confirm the number of treasury shares held is 45,557,120.
- Note that this filing does not contain financial performance data; refer to Form 20-F for quarterly or annual results.